| 1 |
25634537 | Physiologically based pharmacokinetic modeling for 1-bromopropane in F344 rats using gas uptake inhalation experiments. | 2015 May |
1 |
| 2 |
26335194 | Psoralen, a mechanism-based inactivator of CYP2B6. | 2015 Oct 5 |
2 |
| 3 |
24598282 | Metabolism and pharmacokinetics of allitinib in cancer patients: the roles of cytochrome P450s and epoxide hydrolase in its biotransformation. | 2014 May |
1 |
| 4 |
23088752 | Reactive intermediates produced from the metabolism of the vanilloid ring of capsaicinoids by p450 enzymes. | 2013 Jan 18 |
1 |
| 5 |
22859722 | Cytochrome p450 architecture and cysteine nucleophile placement impact raloxifene-mediated mechanism-based inactivation. | 2012 Nov |
1 |
| 6 |
21930824 | Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene. | 2011 Dec |
1 |
| 7 |
12228192 | Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine. | 2002 Oct |
1 |
| 8 |
12460909 | Enhanced bystander cytotoxicity of P450 gene-directed enzyme prodrug therapy by expression of the antiapoptotic factor p35. | 2002 Dec 1 |
1 |
| 9 |
11240372 | The optical interconversion of the P-450 and P-420 forms of neuronal nitric oxide synthase: effects of sodium cholate, mercury chloride and urea. | 2001 Feb |
2 |
| 10 |
8286335 | Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid. | 1994 Jan 11 |
1 |
| 11 |
2192911 | The hepatic glutathione system--influences of xenobiotics. | 1990 |
2 |
| 12 |
4292159 | Reconversion of detergent- and sulfhydryl reagent-produced P-420 to P-450 by polyols and glutathione. | 1967 May 9 |
1 |